30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

ROBIN SHERRINGTON

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
ROBIN SHERRINGTON's trades of Xenon Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-12 2024-06-12
PrS Proposed sale
85,856
456.68
US$894,727 		85,856 456.68 US$894,727
2024-03-08 2024-03-07
S Sale
37,717 +34.3%
201.76
US$4,261,115 		37,717 +34.3% 201.76 US$4,261,115
2024-03-08 2024-03-07
S Sale
18,645 -8.3%
304.51
US$2,875,591 		18,645 -8.3% 304.51 US$2,875,591
2024-03-07 2024-03-07
PrS Proposed sale
7,137
46.28
US$330,288 		7,137 46.28 US$330,288
2022-09-02 2022-09-01
S Sale
8,776 -34.3%
38.80
US$340,509 		8,776 -34.3% 38.80 US$340,509
2022-09-02 2022-09-01
S Sale
35,103 -57.9%
38.03
US$1,334,967 		35,103 -57.9% 38.03 US$1,334,967
2022-09-02 2022-08-31
S Sale
21,352 -56.0%
38.57
US$823,547 		21,352 -56.0% 38.57 US$823,547
2022-03-08 2022-03-04
S Sale
5,000 -22.5%
30.23
US$151,150 		5,000 -22.5% 30.23 US$151,150
2022-03-08 2022-03-04
S Sale
5,000 -18.4%
31.05
US$155,250 		5,000 -18.4% 31.05 US$155,250
2022-03-08 2022-03-04
S Sale
5,000 -15.5%
30.15
US$150,750 		5,000 -15.5% 30.15 US$150,750
2022-03-08 2022-03-04
S Sale
6,710 -17.2%
30.56
US$205,058 		6,710 -17.2% 30.56 US$205,058
2021-06-01 2021-05-28
S Sale
2,912 -8.3%
18.81
US$54,775 		2,912 -8.3% 18.81 US$54,775
2021-06-01 2021-05-28
S Sale
3,155 -8.2%
18.81
US$59,346 		3,155 -8.2% 18.81 US$59,346